David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
PUT
PepsiCo
PEP
$194B
| $10.3M | 0.01% |
84,300
-6,700
| -7% | -$764K |
|
1052
PUT
Mohawk Industries
MHK
$9.06B
| $10.3M | 0.01% |
81,800
+53,300
| +187% | +$6.94M |
|
1053
CALL
Freeport-McMoran
FCX
$115B
| $10.3M | 0.01% |
799,700
-573,700
| -42% | -$6.94M |
|
|
AIMC
1054
DELISTED
Altra Industrial Motion Corp
AIMC
| $10.3M | 0.01% |
331,254
+100,108
| +43% | +$3.03M |
|
|
CERN
1055
DELISTED
Cerner Corp
CERN
| $10.3M | 0.01% |
179,414
+105,309
| +142% | +$5.86M |
|
1056
PUT
Madison Square Garden
MSGS
$9.8B
| $10.3M | 0.01% |
49,070
-2,243
| -4% | -$456K |
|
|
DATA
1057
CALL
DELISTED
Tableau Software, Inc.
DATA
| $10.2M | 0.01% |
80,500
-10,000
| -11% | -$1.26M |
|
1058
Atkore
ATKR
$3.16B
| $10.2M | 0.01% |
474,174
+95,110
| +25% | +$2.13M |
|
|
EGRX
1059
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $10.2M | 0.01% |
201,907
-83,411
| -29% | -$3.71M |
|
|
ATVI
1060
CALL
DELISTED
Activision Blizzard
ATVI
| $10.2M | 0.01% |
+223,900
| New | +$10.1M |
|
1061
CALL
Transocean
RIG
$6.42B
| $10.2M | 0.01% |
1,167,200
+313,100
| +37% | +$2.68M |
|
1062
Avery Dennison
AVY
$13.6B
| $10.1M | 0.01% |
89,583
-274,771
| -75% | -$28.4M |
|
|
1063
CALL
Mohawk Industries
MHK
$9.06B
| $10.1M | 0.01% |
80,000
+27,400
| +52% | +$3.57M |
|
|
FL
1064
DELISTED
Foot Locker
FL
| $10.1M | 0.01% |
165,957
-12,244
| -7% | -$713K |
|
|
SYNH
1065
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $10.1M | 0.01% |
194,277
-337,714
| -63% | -$16.4M |
|
1066
Photronics
PLAB
$1.73B
| $10M | 0.01% |
1,063,095
-188,188
| -15% | -$1.91M |
|
1067
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $10M | 0.01% |
50,000
-16,000
| -24% | -$3.23M |
|
1068
Aptiv
APTV
$9.68B
| $10M | 0.01% |
126,348
-319,151
| -72% | -$24.5M |
|
1069
Ultragenyx Pharmaceutical
RARE
$2.61B
| $10M | 0.01% |
144,177
-177,657
| -55% | -$10.2M |
|
1070
SunCoke Energy
SXC
$828M
| $9.99M | 0.01% |
1,176,920
-347,597
| -23% | -$3.38M |
|
|
MIC
1071
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $9.98M | 0.01% |
242,117
+10,862
| +5% | +$446K |
|
1072
BioMarin Pharmaceuticals
BMRN
$12.8B
| $9.97M | 0.01% |
112,270
-123,499
| -52% | -$11.4M |
|
1073
Healthcare Realty
HR
$6.65B
| $9.97M | 0.01% |
348,715
-265,254
| -43% | -$7.38M |
|
1074
MGIC Investment
MTG
$6.41B
| $9.96M | 0.01% |
755,404
+651,403
| +626% | +$8.11M |
|
|
CBPO
1075
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $9.95M | 0.01% |
109,087
-18,573
| -15% | -$1.52M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.